Fecal Microbiota Transplantation for Radiation Enteritis
Recruiting now · Not applicable
Conditions studied: Radiation Enteritis
In brief
Radiation enteritis is one of the most feared complications after abdominal or pelvic radiation therapy.The gut microbiota is considered to constitute a "microbial organ" which has pivotal roles in the intestinal diseases and body metabolism. Evidence from animal studies demonstrated the link between intestinal bacteria and radiation enteritis. This clinical trial aims to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) for radiation enteritis.
Key facts
- Study ID
- NCT03516461
- Run by
- The Second Hospital of Nanjing Medical University
- People needed
- 70
- Starts
- 2018-01-07
- Expected to finish
- 2025-07-01
- Last updated by the study team
- 2025-03-30
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- age ≥18 years old;
- Radiation enteritis diagnosed by colonoscopy after finishing radiotherapy.
You may not qualify if…
- Patients who were pregnant or nursing;
- Patients who were unable or unwilling to undergo a gastroscopy;
- Patients who had gastrointestinal infection;
- Patients with cardiopulmonary failure.
Where it is running
- Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University — Nanjing, Jiangsu, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.